OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Martyn Bullock, Yan Ren, Christine J. O’Neill, et al.
Clinical Endocrinology (2015) Vol. 85, Iss. 2, pp. 283-290
Open Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Jake R. Conway, Eric Kofman, Shirley S. Mo, et al.
Genome Medicine (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 148
Jake R. Conway, Eric Kofman, Shirley S. Mo, et al.
Genome Medicine (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 148
Effects of CoexistentBRAFV600EandTERTPromoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon, Young Shin Song, Ye An Kim, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 651-660
Closed Access | Times Cited: 140
Shinje Moon, Young Shin Song, Ye An Kim, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 651-660
Closed Access | Times Cited: 140
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Khairul Ramlee, Jing Wang, Wei Hong Toh, et al.
Genes (2016) Vol. 7, Iss. 8, pp. 50-50
Open Access | Times Cited: 139
Muhammad Khairul Ramlee, Jing Wang, Wei Hong Toh, et al.
Genes (2016) Vol. 7, Iss. 8, pp. 50-50
Open Access | Times Cited: 139
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu, Xiaotian Yuan, Dawei Xu
Genes (2016) Vol. 7, Iss. 7, pp. 38-38
Open Access | Times Cited: 137
Tiantian Liu, Xiaotian Yuan, Dawei Xu
Genes (2016) Vol. 7, Iss. 7, pp. 38-38
Open Access | Times Cited: 137
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113
Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features
Xiaoyin “Sara” Jiang, Grant Harrison, Michael Datto
Cancer Cytopathology (2016) Vol. 124, Iss. 12, pp. 893-900
Open Access | Times Cited: 87
Xiaoyin “Sara” Jiang, Grant Harrison, Michael Datto
Cancer Cytopathology (2016) Vol. 124, Iss. 12, pp. 893-900
Open Access | Times Cited: 87
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang, Yanping Gong, Shuping Yan, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 44-57
Open Access | Times Cited: 70
Jing Yang, Yanping Gong, Shuping Yan, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 44-57
Open Access | Times Cited: 70
A six-genotype genetic prognostic model for papillary thyroid cancer
Xiaopei Shen, Rengyun Liu, Mingzhao Xing
Endocrine Related Cancer (2016) Vol. 24, Iss. 1, pp. 41-52
Open Access | Times Cited: 64
Xiaopei Shen, Rengyun Liu, Mingzhao Xing
Endocrine Related Cancer (2016) Vol. 24, Iss. 1, pp. 41-52
Open Access | Times Cited: 64
Multikinase inhibitors in thyroid cancer: timing of targeted therapy
Matti L. Gild, Venessa Tsang, Roderick Clifton‐Bligh, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 4, pp. 225-234
Closed Access | Times Cited: 52
Matti L. Gild, Venessa Tsang, Roderick Clifton‐Bligh, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 4, pp. 225-234
Closed Access | Times Cited: 52
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients
Heera Yang, Hyunju Park, Hyun Jin Ryu, et al.
Endocrinology and Metabolism (2022) Vol. 37, Iss. 4, pp. 652-663
Open Access | Times Cited: 30
Heera Yang, Hyunju Park, Hyun Jin Ryu, et al.
Endocrinology and Metabolism (2022) Vol. 37, Iss. 4, pp. 652-663
Open Access | Times Cited: 30
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
Michiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 58
Michiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 58
Telomerase reverse transcriptase mutations are independent predictor of disease‐free survival in M iddle E astern papillary thyroid cancer
Rong Bu, Abdul K. Siraj, Sasidharan Padmaja Divya, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 10, pp. 2028-2039
Open Access | Times Cited: 53
Rong Bu, Abdul K. Siraj, Sasidharan Padmaja Divya, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 10, pp. 2028-2039
Open Access | Times Cited: 53
TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, et al.
Thyroid (2019) Vol. 29, Iss. 8, pp. 1105-1114
Open Access | Times Cited: 52
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, et al.
Thyroid (2019) Vol. 29, Iss. 8, pp. 1105-1114
Open Access | Times Cited: 52
Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing
Maria Alexiadis, Simone M. Rowley, Simon Chu, et al.
Molecular Cancer Research (2018) Vol. 17, Iss. 1, pp. 177-185
Open Access | Times Cited: 51
Maria Alexiadis, Simone M. Rowley, Simon Chu, et al.
Molecular Cancer Research (2018) Vol. 17, Iss. 1, pp. 177-185
Open Access | Times Cited: 51
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
Claire Bournaud, Françoise Descôtes, Myriam Decaussin‐Petrucci, et al.
European Journal of Cancer (2019) Vol. 108, pp. 41-49
Open Access | Times Cited: 50
Claire Bournaud, Françoise Descôtes, Myriam Decaussin‐Petrucci, et al.
European Journal of Cancer (2019) Vol. 108, pp. 41-49
Open Access | Times Cited: 50
The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
Anqi Jin, Jianhao Xu, Yan Wang
Medicine (2018) Vol. 97, Iss. 29, pp. e11548-e11548
Open Access | Times Cited: 48
Anqi Jin, Jianhao Xu, Yan Wang
Medicine (2018) Vol. 97, Iss. 29, pp. e11548-e11548
Open Access | Times Cited: 48
The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta‐analysis
Bojie Chen, Yuan Shi, Yanan Xu, et al.
Clinical Endocrinology (2020) Vol. 94, Iss. 5, pp. 731-742
Open Access | Times Cited: 42
Bojie Chen, Yuan Shi, Yanan Xu, et al.
Clinical Endocrinology (2020) Vol. 94, Iss. 5, pp. 731-742
Open Access | Times Cited: 42
Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma
Kai‐Ping Chang, Chun‐I Wang, Curtis R. Pickering, et al.
Head & Neck (2017) Vol. 39, Iss. 6, pp. 1131-1137
Closed Access | Times Cited: 48
Kai‐Ping Chang, Chun‐I Wang, Curtis R. Pickering, et al.
Head & Neck (2017) Vol. 39, Iss. 6, pp. 1131-1137
Closed Access | Times Cited: 48
ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer
Martyn Bullock, Grace Lim, Ying Zhu, et al.
Thyroid (2019) Vol. 29, Iss. 11, pp. 1623-1633
Closed Access | Times Cited: 37
Martyn Bullock, Grace Lim, Ying Zhu, et al.
Thyroid (2019) Vol. 29, Iss. 11, pp. 1623-1633
Closed Access | Times Cited: 37
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review
Jingxin Mao, Xingliang Huang, Mohammad K. Okla, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 19
Jingxin Mao, Xingliang Huang, Mohammad K. Okla, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 19
Mechanistic Insights of Thyroid Cancer Progression
Luis J. Leandro‐García, Iñigo Landa
Endocrinology (2023) Vol. 164, Iss. 9
Open Access | Times Cited: 12
Luis J. Leandro‐García, Iñigo Landa
Endocrinology (2023) Vol. 164, Iss. 9
Open Access | Times Cited: 12
Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer
Ye Sang, Guanghui Hu, Junyu Xue, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 304-312
Closed Access | Times Cited: 4
Ye Sang, Guanghui Hu, Junyu Xue, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 304-312
Closed Access | Times Cited: 4
Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study
Hui Shi, Ke Ding, Xiuyan Yang, et al.
Journal of Clinical & Translational Endocrinology (2025), pp. 100390-100390
Open Access
Hui Shi, Ke Ding, Xiuyan Yang, et al.
Journal of Clinical & Translational Endocrinology (2025), pp. 100390-100390
Open Access
